The population risk of fractures attributable to oral corticosteroids

Peter T. Donnan (Lead / Corresponding author), Gillian Libby, Anne C. Boyter, Philip Thompson

    Research output: Contribution to journalArticle

    13 Citations (Scopus)

    Abstract

    Purpose: Previous studies have indicated a relationship between oral corticosteroid use and the risk of fracture, although without population-based comparators or exact dose information. The aim was to estimate the relative and population attributable risk (PAR) of admission for non-traumatic fracture among users of corticosteroids. Methods: The design was a retrospective cohort study of the population of Tayside, Scotland aged 18 or over and resident between 1 January 1993 and 31 January 1997 (n = 280 645). Subjects included were those who redeemed one or more prescriptions for oral corticosteroids compared with those not prescribed corticosteroids (oral or inhaled) in the population. The main outcome measure was the PAR and relative risk of hospital admissions for non-traumatic fracture. Results: Approximately 7.5% of the population received prescriptions for oral corticosteroids. There was a significantly higher risk of fracture in the oral corticosteroid. cohort when exposed to drugs compared with the general population (RR = 1.90, 95%CI 1.68, 2.16), after adjustment. Women were at higher risk than men, especially for vertebral fractures (RR = 5.19, 95%CI 2.95, 9.16). Previous fracture, Parkinsonian and anti-epileptic medication were significantly associated with higher risk, while HRT, NSAIDS and statins were associated with lower risk. An estimate of one in six vertebral and 1 in 13 non-vertebral fractures could be due to oral corticosteroid use in the population. Conclusions: The important public health impact of oral corticosteroids, especially in women needs to be addressed. Greater use of medication to ameliorate the adverse effects of these widely-used drugs is advocated.

    Original languageEnglish
    Pages (from-to)177-186
    Number of pages10
    JournalPharmacoepidemiology and Drug Safety
    Volume14
    Issue number3
    DOIs
    Publication statusPublished - Mar 2005

    Fingerprint

    Adrenal Cortex Hormones
    Population
    Prescriptions
    Hydroxymethylglutaryl-CoA Reductase Inhibitors
    Scotland
    Pharmaceutical Preparations
    Cohort Studies
    Retrospective Studies
    Public Health
    Outcome Assessment (Health Care)

    Keywords

    • Fractures
    • Oral corticosteroids
    • Osteoporosis
    • Public health

    Cite this

    Donnan, Peter T. ; Libby, Gillian ; Boyter, Anne C. ; Thompson, Philip. / The population risk of fractures attributable to oral corticosteroids. In: Pharmacoepidemiology and Drug Safety. 2005 ; Vol. 14, No. 3. pp. 177-186.
    @article{abba72209d4a4c18882addd64b0039c6,
    title = "The population risk of fractures attributable to oral corticosteroids",
    abstract = "Purpose: Previous studies have indicated a relationship between oral corticosteroid use and the risk of fracture, although without population-based comparators or exact dose information. The aim was to estimate the relative and population attributable risk (PAR) of admission for non-traumatic fracture among users of corticosteroids. Methods: The design was a retrospective cohort study of the population of Tayside, Scotland aged 18 or over and resident between 1 January 1993 and 31 January 1997 (n = 280 645). Subjects included were those who redeemed one or more prescriptions for oral corticosteroids compared with those not prescribed corticosteroids (oral or inhaled) in the population. The main outcome measure was the PAR and relative risk of hospital admissions for non-traumatic fracture. Results: Approximately 7.5{\%} of the population received prescriptions for oral corticosteroids. There was a significantly higher risk of fracture in the oral corticosteroid. cohort when exposed to drugs compared with the general population (RR = 1.90, 95{\%}CI 1.68, 2.16), after adjustment. Women were at higher risk than men, especially for vertebral fractures (RR = 5.19, 95{\%}CI 2.95, 9.16). Previous fracture, Parkinsonian and anti-epileptic medication were significantly associated with higher risk, while HRT, NSAIDS and statins were associated with lower risk. An estimate of one in six vertebral and 1 in 13 non-vertebral fractures could be due to oral corticosteroid use in the population. Conclusions: The important public health impact of oral corticosteroids, especially in women needs to be addressed. Greater use of medication to ameliorate the adverse effects of these widely-used drugs is advocated.",
    keywords = "Fractures, Oral corticosteroids, Osteoporosis, Public health",
    author = "Donnan, {Peter T.} and Gillian Libby and Boyter, {Anne C.} and Philip Thompson",
    year = "2005",
    month = "3",
    doi = "10.1002/pds.1075",
    language = "English",
    volume = "14",
    pages = "177--186",
    journal = "Pharmacoepidemiology and Drug Safety",
    issn = "1053-8569",
    publisher = "Wiley",
    number = "3",

    }

    The population risk of fractures attributable to oral corticosteroids. / Donnan, Peter T. (Lead / Corresponding author); Libby, Gillian; Boyter, Anne C.; Thompson, Philip.

    In: Pharmacoepidemiology and Drug Safety, Vol. 14, No. 3, 03.2005, p. 177-186.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - The population risk of fractures attributable to oral corticosteroids

    AU - Donnan, Peter T.

    AU - Libby, Gillian

    AU - Boyter, Anne C.

    AU - Thompson, Philip

    PY - 2005/3

    Y1 - 2005/3

    N2 - Purpose: Previous studies have indicated a relationship between oral corticosteroid use and the risk of fracture, although without population-based comparators or exact dose information. The aim was to estimate the relative and population attributable risk (PAR) of admission for non-traumatic fracture among users of corticosteroids. Methods: The design was a retrospective cohort study of the population of Tayside, Scotland aged 18 or over and resident between 1 January 1993 and 31 January 1997 (n = 280 645). Subjects included were those who redeemed one or more prescriptions for oral corticosteroids compared with those not prescribed corticosteroids (oral or inhaled) in the population. The main outcome measure was the PAR and relative risk of hospital admissions for non-traumatic fracture. Results: Approximately 7.5% of the population received prescriptions for oral corticosteroids. There was a significantly higher risk of fracture in the oral corticosteroid. cohort when exposed to drugs compared with the general population (RR = 1.90, 95%CI 1.68, 2.16), after adjustment. Women were at higher risk than men, especially for vertebral fractures (RR = 5.19, 95%CI 2.95, 9.16). Previous fracture, Parkinsonian and anti-epileptic medication were significantly associated with higher risk, while HRT, NSAIDS and statins were associated with lower risk. An estimate of one in six vertebral and 1 in 13 non-vertebral fractures could be due to oral corticosteroid use in the population. Conclusions: The important public health impact of oral corticosteroids, especially in women needs to be addressed. Greater use of medication to ameliorate the adverse effects of these widely-used drugs is advocated.

    AB - Purpose: Previous studies have indicated a relationship between oral corticosteroid use and the risk of fracture, although without population-based comparators or exact dose information. The aim was to estimate the relative and population attributable risk (PAR) of admission for non-traumatic fracture among users of corticosteroids. Methods: The design was a retrospective cohort study of the population of Tayside, Scotland aged 18 or over and resident between 1 January 1993 and 31 January 1997 (n = 280 645). Subjects included were those who redeemed one or more prescriptions for oral corticosteroids compared with those not prescribed corticosteroids (oral or inhaled) in the population. The main outcome measure was the PAR and relative risk of hospital admissions for non-traumatic fracture. Results: Approximately 7.5% of the population received prescriptions for oral corticosteroids. There was a significantly higher risk of fracture in the oral corticosteroid. cohort when exposed to drugs compared with the general population (RR = 1.90, 95%CI 1.68, 2.16), after adjustment. Women were at higher risk than men, especially for vertebral fractures (RR = 5.19, 95%CI 2.95, 9.16). Previous fracture, Parkinsonian and anti-epileptic medication were significantly associated with higher risk, while HRT, NSAIDS and statins were associated with lower risk. An estimate of one in six vertebral and 1 in 13 non-vertebral fractures could be due to oral corticosteroid use in the population. Conclusions: The important public health impact of oral corticosteroids, especially in women needs to be addressed. Greater use of medication to ameliorate the adverse effects of these widely-used drugs is advocated.

    KW - Fractures

    KW - Oral corticosteroids

    KW - Osteoporosis

    KW - Public health

    UR - http://www.scopus.com/inward/record.url?scp=14944366329&partnerID=8YFLogxK

    U2 - 10.1002/pds.1075

    DO - 10.1002/pds.1075

    M3 - Article

    VL - 14

    SP - 177

    EP - 186

    JO - Pharmacoepidemiology and Drug Safety

    JF - Pharmacoepidemiology and Drug Safety

    SN - 1053-8569

    IS - 3

    ER -